Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2011-11-13 Fund Information / Fact…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Fund Information / Factsheet 2011
Fund Information / Factsheet Classification · 98% confidence The document is explicitly titled "Factsheet Q3 / 2011" and contains summarized financial figures, key performance indicators (KPIs) for the first three quarters of 2011 compared to prior years, segment breakdowns, share information, and a financial calendar. This structure strongly indicates a concise summary document designed for quick investor consumption, rather than a comprehensive annual report (10-K) or a detailed interim report (IR). The definition for Fund Information / Factsheet (FS) is the most appropriate fit for a document labeled 'Factsheet' containing summarized financial data.
2011-11-13 English
Investor Presentation 2011
Investor Presentation Classification · 99% confidence The document is explicitly titled '# Factsheet Q3/2011' and contains detailed key performance indicators (Konzernkennzahlen) for the first three quarters (Q1-3/11) compared to previous full years (2010, 2009, 2008). It also includes a company profile, business segment breakdowns, stock information, and a financial calendar. This structure perfectly matches the definition of a 'Fund Information / Factsheet' (FS), which is described as a brief summary of key company facts and financials. Although it contains quarterly data, it is presented as a summary factsheet rather than a comprehensive regulatory report like an Interim Report (IR) or Annual Report (10-K).
2011-11-13 German
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managing body ("Dr. Ulf M. Schneider, Position: Member of a managing body"). It reports the exercise of stock options and subsequent sale of shares, which falls directly under the definition of insider trading or director transactions. This matches the definition for 'Director's Dealing' (DIRS). The document structure and content confirm this classification.
2011-11-11 English
Report Publication Announcement 2011
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1700 chars) dated November 8, 2011, from Fresenius SE & Co. KGaA. The key phrases are 'Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG' and 'Fresenius SE & Co. KGaA hereby announces that the following financial reports shall be disclosed: Report: Quarterly financial report within the 2nd half-year. Date of disclosure / German: November 09, 2011'. This document is not the Quarterly Financial Report itself, but rather an announcement about the *timing* and *disclosure* of that report, specifically noting a change in the publication date. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published fits the definition of a Report Publication Announcement (RPA).
2011-11-08 English
Q3 Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group covering the 1st to 3rd quarters of 2011. It contains comprehensive financial statements (income, cash flow, balance sheet), segment reporting, and a detailed management report. It is not an earnings release (which would be a short summary) nor a report publication announcement (as it contains the full report content). Therefore, it is classified as an Interim/Quarterly Report. 9M 2011
2011-11-07 German
Analyst Conference Call - Q3/11 Results
Call Transcript Classification · 98% confidence The document text is titled "# Analyst Conference Call – Q1-3/11 Results" and contains detailed financial figures, segment breakdowns, and updates for Q1-3/11, followed by specific segment updates (Fresenius Kabi, Helios, Vamed) and a section on Cash Flow Development. The structure, including the 'Safe Harbor Statement', segment-by-segment analysis, and detailed tables, is characteristic of a transcript from an earnings call where management discusses quarterly performance. The presence of 'Analyst Conference Call' in the title strongly points to a Call Transcript (CT). It is not a formal regulatory filing like a 10-K or IR, nor is it just a brief announcement (RPA/ER).
2011-11-02 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.